AI-generated summary
The authors report a systematic review of six included studies on photobiomodulation for trigeminal neuralgia, involving 193 patients compared with conventional therapies, TENS, or combinations with pharmacotherapy. They describe the overall risk of bias as low, with some concerns about randomization and double-blinding. They conclude that photobiomodulation appears as effective as conventional therapies and may be a coadjuvant option, though few reports exist.
- Participants
- 193
- Studies included
- 6
- Who or what was studied
- Patients with trigeminal neuralgia
- Limits stated in the abstract
- Only six studies were included, there are few reports in the literature, and some concerns exist about randomization and double-blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Risk of bias, Blinding. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.